These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2573445)

  • 1. Predictability of antihypertensive responsiveness and alpha-adrenoceptor antagonism during prazosin treatment.
    Elliott HL; Donnelly R; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1989 Nov; 46(5):576-83. PubMed ID: 2573445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-effect relationships and individual responses to doxazosin in essential hypertension.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1989 Nov; 28(5):517-26. PubMed ID: 2531605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha adrenergic blockade by prazosin in therapy of essential hypertension.
    Ram CV; Anderson RJ; Hart GR; Crumpler CP
    Clin Pharmacol Ther; 1981 Jun; 29(6):719-22. PubMed ID: 6112091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man.
    Vincent J; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1983 Jun; 15(6):719-25. PubMed ID: 6135439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.
    Eichler HG; Ford GA; Blaschke TF; Swislocki A; Hoffman BB
    J Clin Invest; 1989 Jan; 83(1):108-12. PubMed ID: 2562959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist.
    de Leeuw PW; Ligthart JJ; Smout AJ; Birkenhäger WH
    Eur J Clin Pharmacol; 1982; 23(5):397-401. PubMed ID: 6129979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect.
    Naslund TC; Merrell WJ; Nadeau JH; Wood AJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):699-703. PubMed ID: 2904312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.
    Hamilton CA; Reid JL; Vincent J
    Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age on the sensitivity of the alpha 1-adrenoceptor to phenylephrine and prazosin.
    Klein C; Gerber JG; Payne NA; Nies AS
    Clin Pharmacol Ther; 1990 Apr; 47(4):535-9. PubMed ID: 2158407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
    Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
    Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and therapeutic role of prazosin and related alpha-adrenoceptor antagonists.
    Reid JL; Vincent J
    Cardiology; 1986; 73(3):164-74. PubMed ID: 2872958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma prazosin concentration and alpha-antagonism in humans: comparison of conventional and rate-controlled (Oros) formulations.
    Elliott HL; Vincent J; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1988 May; 43(5):582-7. PubMed ID: 2835200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K; Baba A; Akima M; Koga T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1989; 299():169-84. PubMed ID: 2570554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
    Goering J; Zimmerman BG
    J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of the effects of alpha 1-adrenergic blockade on blood pressure and renin release in patients with essential hypertension.
    Morganti A; Sala C; Palermo A; Turolo L; Zanchetti A; Laragh J
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S158-61. PubMed ID: 6175832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.